Defining optimal sulbactam regimens for treatment of Acinetobacter baumannii pneumonia and impact of blaOXA-23 on efficacy. Abouelhassan Y, Nicolau DP, Abdelraouf K. J Antimicrob Chemother 2024;79:2306-2316.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abouelhassan Y, Nicolau DP, Abdelraouf K. Defining optimal sulbactam regimens for treatment of Acinetobacter baumannii pneumonia and impact of blaOXA-23 on efficacy. J Antimicrob Chemother 2024;79:2306-2316.
PMID: 38997215